SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-16-002720
Filing Date
2016-02-29
Accepted
2016-02-29 16:18:43
Documents
4
Effectiveness Date
2016-02-29

Document Format Files

Seq Description Document Type Size
1 e614709_f6pos-teva.htm F-6 POS 129855
2 e614709_ex99-a2.htm EX-99.(A)(2) 141232
3 e614709_ex99-e.htm EX-99.(E) 7071
4 GRAPHIC cover.jpg GRAPHIC 37273
  Complete submission text file 0001193805-16-002720.txt   331213
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-208239 | Film No.: 161467993
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 NEW YORK PLAZA 13TH FLOOR NEW YORK NY 10004
Business Address 4 NEW YORK PLAZA 13TH FLOOR NEW YORK NY 10004 212-319-7600
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) CIK: 0001474274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: F-6 POS